CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net income	$ 135,056	$ 138,401	$ 142,897
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	170,212	166,545	144,543
Amortization of deferred debt financing costs	3,268	3,270	3,239
Stock-based compensation expense	19,066	16,775	19,429
Deferred income taxes	35,529	(6,481)	(591)
Loss (gain) on sale of property, plant and equipment	2,143	(237)	585
Loss on extinguishment of debt	0	2,549	0
Other	(2,972)	376	(325)
Change in operating assets and liabilities, net of business acquisitions:
Trade and other receivables, net	1,808	10,847	8,923
Inventories	(24,959)	(1,863)	162,181
Prepaid expenses and other assets	(8,761)	(7,609)	(3,931)
Accounts payable, accrued liabilities and other	(976)	4,268	(68,278)
Net cash provided by operating activities	329,414	326,841	408,672
Cash flows from investing activities
Purchases of property, plant, and equipment	(82,921)	(75,682)	(58,987)
Proceeds from sale of property, plant, and equipment	2,755	2,411	1,362
Business acquisitions, net of cash acquired	(121,740)	(411,747)	(25,859)
Purchase of intangible assets and other investing activities	(4,580)	(27,831)	(3,061)
Net cash used in investing activities	(206,486)	(512,849)	(86,545)
Cash flows from financing activities
Term debt borrowings	0	125,000	0
Term debt repayments	(6,250)	(130,938)	(7,500)
Borrowing on revolver	744,426	1,320,385	488,440
Repayments on revolver	(769,426)	(1,220,385)	(568,728)
Repayment of convertible notes	0	0	(172,500)
Proceeds from senior notes offering	0	500,000	0
Repayment of senior notes	0	(300,000)	0
Cash dividends paid to shareholders	(55,274)	(50,187)	(42,140)
Stock repurchases under buyback program	(31,969)	(4,661)	(18,808)
Taxes paid for share-based payment arrangements	(10,932)	(17,334)	(12,132)
Payment of deferred financing costs	0	(9,212)	0
Payment of contingent consideration from business acquisitions	(48)	(4,652)	(1,460)
Proceeds from exercise of common stock options	0	21	1,413
Other financing activities	(584)	123	(150)
Net cash (used in) provided by financing activities	(130,057)	208,160	(333,565)
Net (decrease) increase in cash and cash equivalents	(7,129)	22,152	(11,438)
Cash and cash equivalents at beginning of year	33,561	11,409	22,847
Cash and cash equivalents at end of year	$ 26,432	$ 33,561	$ 11,409